These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28530032)

  • 21. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
    Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
    BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.
    Barbosa JR; Colares JKB; Flores GL; Cortes VF; Miguel JC; Portilho MM; Marques VA; Potsch DV; Brandão-Mello CE; Amendola-Pires M; Pilotto JH; Lima DM; Lampe E; Villar LM
    J Virol Methods; 2017 Oct; 248():244-249. PubMed ID: 28782578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients.
    Long L; Shen T; Gao J; Duan Z; Liang H; Lu F
    BMC Infect Dis; 2014 Nov; 14():577. PubMed ID: 25371245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation.
    Antonucci G; Vairo F; Iacomi F; Comandini UV; Solmone M; Piselli P; Boumis E; Lauria FN; Capobianchi MR; Ippolito G; Puro V
    Scand J Infect Dis; 2008; 40(11-12):928-34. PubMed ID: 18651264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
    Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
    J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Wang Q; De Luca A; Smith C; Zangerle R; Sambatakou H; Bonnet F; Smit C; Schommers P; Thornton A; Berenguer J; Peters L; Spagnuolo V; Ammassari A; Antinori A; Quiros-Roldan E; Mussini C; Miro JM; Konopnicki D; Fehr J; Campbell MA; Termote M; Bucher HC;
    Ann Intern Med; 2017 Jan; 166(1):9-17. PubMed ID: 27750294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
    Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
    Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing for hepatitis B virus and HIV in patients with chronic hepatitis C: screening performance and outcome.
    Bolther M; Dalgaard LS; Kristensen LH; Tarp BD; Jensen-Fangel S
    Scand J Infect Dis; 2014 Oct; 46(10):686-92. PubMed ID: 25134654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.
    Flores GL; de Almeida AJ; Miguel JC; Cruz HM; Portilho MM; Scalioni Lde P; Marques VA; Lewis-Ximenez LL; Lampe E; Villar LM
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26978383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two immunoassays for concurrent detection of HCV antigen and antibodies among HIV/HCV co-infected patients in dried serum/plasma spots.
    Eshetu A; Hauser A; Schmidt D; Bartmeyer B; Bremer V; Obermeier M; Ehret R; Volkwein A; Bock CT; Bannert N
    J Virol Methods; 2020 May; 279():113839. PubMed ID: 32087189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia.
    Abera B; Adem Y; Yimer M; Mulu W; Zenebe Y; Mekonnen Z
    Virol J; 2017 Feb; 14(1):21. PubMed ID: 28166829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study.
    Njouom R; Pasquier C; Ayouba A; Tejiokem MC; Vessiere A; Mfoupouendoun J; Tene G; Eteki N; Lobe MM; Izopet J; Nerrienet E
    Am J Trop Med Hyg; 2005 Aug; 73(2):460-6. PubMed ID: 16103623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of core antigen of hepatitis virus C in patients infected with hepatitis virus C and B].
    Cao H; Zhang K; Shu X; Xu QH; Li G
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):726-8. PubMed ID: 22409841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral hepatitis and HIV infection among injection drug users in a central Iranian City.
    Sofian M; Aghakhani A; Banifazl M; Azadmanesh K; Farazi AA; McFarland W; Eslamifar A; Ramezani A
    J Addict Med; 2012 Dec; 6(4):292-6. PubMed ID: 22895463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.